Brief: Curis Doses First Five Patients In Takeaim Cll Study
30/07/2026 13:10
BRIEF-Curis Doses First Five Patients In Takeaim Cll Study July 30 (Reuters) - Curis Inc CRIS.O:
CURIS DOSES FIRST FIVE PATIENTS IN TAKEAIM CLL STUDY
Source text: ID:nPn12xSrHa
Further company coverage: CRIS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Curis
See all newsCuris Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Curis Announces Pricing Of $5.6 Million Public Offering
Curis Inc expected to post a loss of $7.84 a share - Earnings Preview
Curis Inc expected to post a loss of $7.47 a share - Earnings Preview
Brief: Curis Doses First Five Patients In Takeaim Cll Study